Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
Authors: Skiöldebrand E, Lorenzo P, Zunino L, Rucklidge G J, Sandgren B, Carlsten J, Ekman S
Journal: Equine veterinary journal
Summary
# Editorial Summary: Synovial Biomarkers of Carpal Joint Damage in Working Horses Understanding how cartilage breakdown manifests in synovial fluid could help clinicians detect early degenerative changes in performance horses before structural damage becomes severe. Researchers measured three key cartilage degradation products—collagen type II, aggrecan, and COMP (cartilage oligomeric matrix protein)—in synovial fluid and serum samples from 73 middle carpal joints across two horse populations: 52 Standardbred trotters and 21 Swedish Warmblood riding horses, classifying joints as normal, mildly lesioned, or moderately lesioned. Both COMP and aggrecan concentrations in synovial fluid from Standardbreds with moderate cartilage damage were notably lower than in normal joints (COMP dropped from 16.6 to 12.0 μg/ml; aggrecan fell from 93.0 to 68.1 μg/ml), whereas Warmbloods showed a slight increase in synovial COMP with moderate damage—a striking breed-dependent difference that likely reflects differing loading patterns and metabolic responses to joint stress. Collagen type II levels were substantially higher in Warmblood synovial fluid overall (8.8 versus 1.6 μg/ml) regardless of cartilage status, suggesting breed-specific baseline markers rather than damage indicators. These findings indicate that biomarker interpretation requires breed-specific reference ranges and caution against assuming uniform synovial profiles; clinicians should consider developing breed-tailored diagnostic thresholds when monitoring high-value performers for subclinical arthropathy.
Read the full abstract on PubMed
Practical Takeaways
- •Synovial fluid biomarker profiles differ between horse breeds and activity types; interpretation of cartilage injury markers should account for breed-specific metabolic characteristics
- •Decreased COMP and aggrecan in synovial fluid may indicate progression of cartilage degeneration in performance horses, potentially useful for staging osteoarthritis severity
- •Collagen type II release patterns differ between breeds, suggesting different biomechanical loading and cartilage degradation mechanisms that may inform breed-specific management of middle carpal joint disease
Key Findings
- •COMP and aggrecan concentrations decreased in synovial fluid from Standardbred trotters with moderate lesions (COMP 16.6 to 12.0 µg/ml; aggrecan 93.0 to 68.1 µg/ml) compared to normal joints
- •Swedish Warmblood horses showed different biomarker patterns than Standardbreds, with slightly increased COMP in moderate lesions and higher collagen type II levels overall (8.8 vs 1.6 µg/ml)
- •Aggrecan/COMP ratio in synovial fluid from moderate lesions was significantly higher in Standardbreds (6.2) than Warmbloods (3.4), suggesting breed-specific metabolic responses
- •COMP synthesis in articular cartilage was markedly lower in osteoarthritic joints compared to normal joints, with greater reduction in moderate versus mild lesions